Chikwamba, Rachel KLotter, TRamesaar, K2008-12-112008-12-112006-02-28Chikwamba, RK, Lotter, T and Ramesaar, K. 2006. Novel platforms for essential biomolecules: expression of antibodies in plants. CSIR Research and Innovation Conference: 1st CSIR Biennial Conference, CSIR International Convention Centre Pretoria, 27-28 February 2006, pp 27http://hdl.handle.net/10204/2726CSIR Research and Innovation Conference: 1st CSIR Biennial Conference, CSIR International Convention Centre Pretoria, 27-28 February 2006The demand for health products such as protein therapeutics and sub-unit vaccines to control infectious diseases far outweighs the current global production capacity of these molecules. These products are currently being produced in conventional fermentation and mammalian cell culture-based platforms. The products are expensive, not readily accessible to developing countries and, in mammalian cell culture products, also carry the risk of infection from contaminating mammalian pathogens. Clearly there is a need for new and innovative platforms to be added to the pharmaceuticals production technologiesenBiomoleculesAntibodiesProtein productionPharmaceuticalsPlant biotechnologyConference PresentationChikwamba, R. K., Lotter, T., & Ramesaar, K. (2006). Novel platforms for essential biomolecules: expression of antibodies in plants. http://hdl.handle.net/10204/2726Chikwamba, Rachel K, T Lotter, and K Ramesaar. "Novel platforms for essential biomolecules: expression of antibodies in plants." (2006): http://hdl.handle.net/10204/2726Chikwamba RK, Lotter T, Ramesaar K, Novel platforms for essential biomolecules: expression of antibodies in plants; 2006. http://hdl.handle.net/10204/2726 .TY - Conference Presentation AU - Chikwamba, Rachel K AU - Lotter, T AU - Ramesaar, K AB - The demand for health products such as protein therapeutics and sub-unit vaccines to control infectious diseases far outweighs the current global production capacity of these molecules. These products are currently being produced in conventional fermentation and mammalian cell culture-based platforms. The products are expensive, not readily accessible to developing countries and, in mammalian cell culture products, also carry the risk of infection from contaminating mammalian pathogens. Clearly there is a need for new and innovative platforms to be added to the pharmaceuticals production technologies DA - 2006-02-28 DB - ResearchSpace DP - CSIR KW - Biomolecules KW - Antibodies KW - Protein production KW - Pharmaceuticals KW - Plant biotechnology LK - https://researchspace.csir.co.za PY - 2006 T1 - Novel platforms for essential biomolecules: expression of antibodies in plants TI - Novel platforms for essential biomolecules: expression of antibodies in plants UR - http://hdl.handle.net/10204/2726 ER -